DrugPatentWatch Database Preview
IMODIUM Drug Profile
» See Plans and Pricing
Which patents cover Imodium, and what generic alternatives are available?
Imodium is a drug marketed by J And J Consumer Inc and Janssen Pharms and is included in eight NDAs. There is one patent protecting this drug and one Paragraph IV challenge.
The generic ingredient in IMODIUM is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
US ANDA Litigation and Generic Entry Outlook for Imodium
There is one Paragraph IV patent challenge for this drug. This may lead to patent invalidation or a license for generic production.
Indicators of Generic Entry
Summary for IMODIUM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 8 |
| Bulk Api Vendors: | 37 |
| Clinical Trials: | 22 |
| Patent Applications: | 3,263 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | IMODIUM at DailyMed |
Recent Clinical Trials for IMODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Naia Pharmaceuticals | Phase 1/Phase 2 |
| McNeil AB | Phase 1 |
| University of North Carolina, Chapel Hill | Phase 2 |
US Patents and Regulatory Information for IMODIUM
Expired US Patents for IMODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | IMODIUM | loperamide hydrochloride | CAPSULE;ORAL | 017694-001 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Janssen Pharms | IMODIUM | loperamide hydrochloride | SOLUTION;ORAL | 019037-001 | Jul 31, 1984 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for IMODIUM
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Switzerland | 553182 | Start Trial |
| Japan | S5754508 | Start Trial |
| Hong Kong | 78076 | Start Trial |
| Spain | 391633 | Start Trial |
| France | 2100711 | Start Trial |
| Netherlands | 173848 | Start Trial |
| Denmark | 137382 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for IMODIUM
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0428296 | SPC/GB98/013 | United Kingdom | Start Trial | PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
